Back to search

France· FR:65964911

AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion

A medicinal product containing amphotéricine b liposomale, registered in France by GILEAD SCIENCES.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAMBISOME liposomal 50 mg, poudre pour…ATC—REGISTER NO.FR:65964911PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
AMPHOTÉRICINE B LIPOSOMALE
Manufacturer
GILEAD SCIENCES
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400956240821
    10 flacon(s) en verre de 50 mg de poudre avec filtre(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Amphotéricine b liposomale in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amphotéricine b liposomale products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ambisome Liposomal, Ampho-Moronal
  • Belgium · Ambisome Liposomales, Amfotericine B Liposomaal Tillomed
  • Bulgaria · Амфотерицин B Липозомал Тиломед
  • Cyprus · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
  • Czechia · Abelcet Lipid Complex, Amfotericin B Liposomal Tillomed
  • Germany · Ambisome Liposomal, Ampho-Moronal
  • Denmark · Ambisome Liposomal
  • Estonia · Amphotericin B Liposomal Tillomed
  • Spain · Abelcet Complejo Lipídico, Ambisome Liposomal
  • Finland · Ambisome Liposomal, Fungizone
  • United Kingdom (Northern Ireland) · Amphotericin B Liposomal Gilead, Amphotericin B Liposomal Sun Pharma
  • Greece · Ambisome Liposomal
  • Hungary · Abelcet, Ambisome Liposzómás
  • Ireland · Ambisome liposomal, Amphotericin B Liposomal Tillomed
  • Iceland · Ambisome Liposomal
  • Italy · Ambisome Liposomiale, Fungizone
  • Luxembourg · Abelcet Lipid Complex, Ambisome Liposomales
  • Latvia · Ambisome liposomāls, Amphotericin B Tillomed
  • Malta · Ambisome Liposomal
  • Netherlands · Ambisome liposomale, Amfotericine B Liposomaal Tillomed
  • Norway · Ambisome Liposomal
  • Poland · Abelcet, Ambisome Liposomal
  • Portugal · Abelcet, Ambisome Lipossomal
  • Romania · Ambisome liposomal, Amfotericină B Lipozomală Tillomed
  • Sweden · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
  • Slovenia · Ambisome Liposomal, Amfotericin B Liposomal Tillomed
  • Slovakia · Abelcet Lipid Complex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a7b0fb19-e39e-4d8a-92e9-c0ca069aa3de
GET /v1/drugs/a7b0fb19-e39e-4d8a-92e9-c0ca069aa3de?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65964911",
  "date_amm": "1998-06-02",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "AMPHOTÉRICINE B LIPOSOMALE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour dispersion pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about amphotéricine b liposomale.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.